Work Package Leaders
Luca Sangiorgi
Istituto Ortopedico Rizzoli, (Bologna, Italy)
Luca Sangiorgi holds a Medical Degree from the Bologna University, a Clinical Genetics PhD at “La Sapienza” Rome University and a Master Degree in Research Promotion and Governance in Hospital Trusts and Local Health Units at the Modena and Reggio Emilia University.
Luca Sangiorgi, Director of Department of Rare Skeletal Disorders, is the coordinator of the Rare Diseases Centre of Rizzoli
Ortopaedic Institute and responsible of 4 National Registers of Rare Disease (Multiple Hereditary Exostoses, Osteogenesis Imperfecta, Ehlers-Danlos Syndrome, Ollier Disease and Maffucci Syndrome). He is the coordinator of BIOGEN, diagnostic and research genetic biobank, and of Telethon Network of Genetic Biobanks.
Since March 2017, he is the coordinator ERN-BOND and currently the chair of the ERN Coordinators Group. Since January 2024 id the delegated for the competent authority for the joint action JARDIN.
He is the first author who has contributed to more than 100 articles published in impacted journals such as Nature Genetics, American Journal of Human Genetics, PLOS Genetics, Human Mutation, Orphanet Journal of Rare Diseases, Journal of Clinical Oncology and International Journal of Cancer.
Valérie Cormier-Daire
Valerie Cormier-Daire (MD, PhD) is Professor of Genetics at the University Paris Centre. She is heading the French reference center for constitutional bone disorders involved in the diagnosis, management and long term follow up of patients with osteochondrodysplasia. She is also Head of the Genetic Clinic Unit in Necker Hospital (since 01/2/2017) and of a research team, since 1998, in INSERM Unit UMR1163 (Imagine Institute) entitled “Molecular and physiopathological basis of osteochondrodysplasia”. She created a specific academic training course on skeletal dysplasia (university diploma) as one for medical students on Rare Disorders. She is involved in a number of national and international scientific societies and patient associations.
She is the author of 445 peer reviewed publications and laureate of 8 national and international awards, She is partner in 8 industrial projects on clinical trials dedicated to skeletal dyspasia and is owner of 2 patents.
Karen E. Heath
Karen Heath is coordinator of the Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario la Paz, Madrid (since 02/2024). Her titles are in clinical molecular genetics and she is a certified clinical laboratory geneticist, with certification from the European Board of Medical Genetics. Since 2008 she leads the Skeletal dysplasia diagnostic and research group. She co-founded the Skeletal dysplasia multidisciplinary unit in her hospital and organises the Annual meeting of the Unit to which heathcare specialists from all over Spain, other European countries and from South America attend. She is member of many genetic societies and the International Society of Skeletal dysplasias (ISDS). Her laboratory provides genetic diagnostic service for numerous Spanish, Portugues and South American hospitals. She is also an assessor in the European Molecular Quality Network (EMQN) schemes. She has many international collaborations and has published more than 100 papers (ORCID 0000-0002-5816-7044) in the identification and characterization of genetic defects in skeletal and growth disorders, with special interest in SHOX and the NPR-B/CNP/FGFR3 signalling pathways in human growth.
Sérgio B. Sousa
Medical Geneticist
Hospital Pediátrico de Coimbra, Coimbra, Portugal
Sérgio B. Sousa is a Medical Genetics specialist at the Hospital Pediátrico de Coimbra in Portugal. He obtained his medical degree from the University of Coimbra, where he subsequently did his Medical Genetics specialization. He did an MSc in Molecular Medicine and Oncology at the University of Porto. Sérgio has received several awards including the John M. Opitz Young Investigator Award in 2010 for his work in Nicolaides-Baraitser Syndrome. He trained in multiple centres across Europe, including the Centre de Référence des Maladies Osseuses Constitutionnelles, Hôpital Necker-Enfants Malades, Paris, and completed his PhD in 2014 at the UCL Institute of Child Health – Great Ormond Street Hospital, London, focused on identifying novel genes for rare unsolved syndromes.He is the President-elect of the Portuguese Society of Human Genetics for 2025, of which he has previously been a member of the Scientific Committee and of the Board. He was also member Board Member of the European Society of Human Genetics 2019-2024. He is a reviewer for a number of journals including the European Journal of Human Genetics, American Journal of Human Genetics, and European Journal of Medical Genetics. He has over 20 years’ experience in Medical Genetics, with special interests in dysmorphology and skeletal dysplasia, and is the Coordinator of the skeletal dysplasia multidisciplinary team at the Unidade Local de Saúde de Coimbra.
Natasha Appelman-Dijkstra
(Activity on EURR-Bone)
Natasha Appelman-Dijkstra is an internist-endocrinologist specialized in osteoporosis, metabolic bone and mineral diseases at the Leiden University Medical Center (LUMC). Since 2016 she is the head of the metabolic bone unit in Leiden and since 2022, she also chairs the Academic training program for Internal Medicine at the LUMC and surrounding hospitals. Natasha serves in multiple international committees and is the director of the international Fibrous Dysplasia Consortium.
She is a PI in several investigator initiated and industry sponsored studies in the field of impact micro indentation, rare bone diseases (focus on Fibrous Dysplasia/McCune Albright syndrome), osteoporosis, phosphate disorders and parathyroid disorders. Since 2020 Natasha is the coordinator of ERN BOND’s affiliated registry EuRR-Bone (European Registry for Rare Bone and Mineral conditions). EuRR-Bone has been working closely together with Endo-ERN’s registry, EuRRECa (European Registry for Rare endocrine conditions), over the last couple of years, and in 2023, they seamlessly merged under the unified banner of EuRREB: European Registries for Rare Endocrine and Bone conditions (www.eurreb.eu), with Natasha as coordinator. In June 2024, she was appointed professor of Internal Medicine of the LUMC, specialising in bone and mineral disorders.
Lena Lande Wekre
Lena Lande Wekre, MD, PhD, works as Senior Consultant in the Skeletal Dysplasia team at TRS National Resource Center for Rare Disorders, Sunnaas Rehabilitation Hospital, Norway.
She has been working in the field of rare disorders since 1999, especially with connective tissue disorders and skeletal dysplasias including Arthrogryposis Multiplex Congenita. As part of her PhD, she conducted a population-based study on adults with Osteogenesis Imperfecta. She collaborates closely with the Section of Children’s Orthopaedics and Reconstructive Surgery, Department of Medical Genetics and Department of Paediatrics, Oslo University Hospital (OUS), in three multidisciplinary clinics for respectively skeletal dysplasias, osteogenesis imperfecta and achondroplasia. Together with the Section of Children’s Orthopaedics, OUS, she is currently working on a Norwegian registry for rare bone disorders (all ages).
She has worked as a medical advisor in the Norwegian National Unit on Rare Disorders, been Orphanet-coordinator, and represented Norway in the EU initiated project for rare disorders, RD-action. She has always collaborated closely with several patient-associations, and been (is) a member of some Medical Advisory Boards.
Joachim Horn
Joachim Horn is a pediatric orthopaedic surgeon and associate professor at Oslo University Hospital. His key qualifications and clinical responsibilities are limb lengthening and reconstruction in children and adults, rare bone disorders and foot and ankle surgery.
Since 2012 he is the head of Children’s Orthopaedics and Reconstructive Surgery at Oslo University Hospital, and since 2016 he is leading the National Norwegian Surgical Unit for Congenital Lower Limb Deformities in Children. Joachim Horn is an active member of EPOS (European Pediatric Orthopeadic Society). He was leading the Genetic & Metabolic Study in EPOS from 2021-2024 and he is an active member of the Educational Committee in EPOS since 2019. He is also former president and current board member of the Nordic Limb Lengthening and Reconstruction Society (Nordic LLRS).
Besides his clinical work he is quite active in research. He was a research fellow at the AO Research Institute in Davos, Switzerland, in 2003 and 2004 and achieved his PhD degree in 2011. In 2019 he was appointed an associate professorship at the University of Oslo, which includes education of medical students and research leadership. The core areas of his research are biomechanics of intramedullary nailing, clinical research on rare bone diseases, growth modulation, femoral anteversion, limb lengthening and reconstruction and Developmental Dysplasia of the Hip (DDH).